Quality and Analytical Testing

How Is Peptide Stability Tested?

Reviewed by the MOL Changes synthesis and analytical teams November 2026

Quick answer

Peptide stability is tested by storing the material under defined conditions and measuring the same critical attributes over time: appearance, HPLC purity, identity by mass, water content and, for solutions, pH. Forced degradation studies show which stress pathways matter. Accelerated studies estimate sensitivity, and real-time studies at the intended storage condition support the retest date.

Key facts at a glance

Study types Forced degradation, accelerated, and real-time long-term
Typical time points T=0, 1, 3, 6 months; 12 and 24 months for real-time studies
Storage conditions −20 °C or −80 °C, desiccated, protected from light
Key attributes Appearance, HPLC purity, mass identity, water content, pH for solutions
Stress conditions Heat, acid, base, oxidation, light and repeated freeze-thaw
Research material A retest date rather than a pharmaceutical expiry date

The degradation pathways that limit peptide shelf life

Peptides degrade by a small number of well-characterised routes. Knowing which one applies to a sequence tells you what to measure and how to store it.

PathwayMain triggersWhat the data shows
HydrolysisWater, heat, extremes of pH; Asp-Pro bonds are especially labileLoss of main peak; +18 Da per cleavage on mass spectrometry
DeamidationNeutral to alkaline pH, heat, time+0.98 Da; a shoulder or a later-eluting peak
OxidationOxygen, light, trace metals; Met, Cys and Trp residues+16 Da steps; colour change; new hydrophobic peaks
IsomerisationHeat and alkaline pH at aspartateSame mass; a co-eluting isoaspartate peak; loss of potency
AggregationHigh concentration, interfaces, freeze-thawMonomer loss by size-exclusion, turbidity, filter blocking
PhotodegradationUltraviolet or visible lightNew peaks and discolouration, often with aromatic residues
AdsorptionContainer surfaces at low concentrationLow recovery without a chemical change

Two practical consequences follow. First, a stability-indicating HPLC method must resolve the degradants from the main peak; a method that cannot separate deamidated from native peptide will report a flat purity trend while the molecule is changing. Second, storage advice should target the pathway that actually threatens the sequence, which is why a methionine-containing peptide needs antioxidant or oxygen exclusion more than a lower temperature alone.

Forced degradation: stressing the molecule on purpose

Forced degradation, sometimes called stress testing, exposes the peptide to conditions far harsher than normal storage: acid and base hydrolysis, hydrogen peroxide oxidation, elevated temperature, light exposure and repeated freeze-thaw cycles. The aim is not to assign a shelf life. It is to discover which degradation products can form, and to prove that the analytical method can separate them.

The output is a degradation profile: a list of products with their mass shifts and retention times, and evidence that the purity method resolves each one from the parent. That evidence is what makes a stability study interpretable, because a purity value that never moves may mean the molecule is stable or that the method is blind. For research peptides, a compact forced degradation package on a representative sequence is often enough; for a development programme, it becomes part of method validation under ICH Q2(R1).

Accelerated and real-time studies

Accelerated studies store the material at elevated temperature and humidity to compress months of change into weeks. For a lyophilised peptide, temperatures of 25 °C and 40 °C are typical, sometimes with controlled humidity to test the powder and the container. The data indicate sensitivity and rank formulation or packaging options, but they do not by themselves set a shelf life, because degradation at 40 °C may follow a different route from degradation at −20 °C.

Real-time studies store the material under the intended condition and measure it at intervals, commonly T=0, 1, 3, 6, 12 and 24 months. This is the data that supports the retest date. ICH Q1A sets out the general design for drug substances and products, and although a research peptide is not a regulated product, the same logic applies: define the condition, define the attributes, define what counts as significant change, and evaluate the trend rather than a single point. A purity drop from 98.4% to 98.1% over six months at −20 °C is a plateau; a drop to 91% is a storage instruction that needs rewriting.

Lyophilised powder versus solution

Water is the substrate for hydrolysis and the medium for aggregation, so removing it buys time. A well-lyophilised peptide stored dry at −20 °C can remain within specification for two years or more. A solution of the same peptide at neutral pH may lose measurable purity in weeks at room temperature, and the rate roughly doubles for every 10 °C of warming, which is the practical version of the Arrhenius relationship.

Solutions add variables that powder does not have: pH, buffer species, ionic strength, preservative, oxygen and container surface. Many peptides are most stable between pH 4 and 6, but solubility often pushes formulations to higher pH, and the two requirements have to be balanced. If a solution must be stored, aliquot it, avoid repeated freeze-thaw, use low-binding tubes at low concentration, and test purity after the first thaw rather than assuming the frozen state is protective. The handling side is covered in how to store peptides.

The test panel at each time point

A stability study is only as useful as the attributes it measures. The following panel is a practical minimum for a research peptide, applied at each interval.

AttributeMethodT=01 month3 months6 months
AppearanceVisual inspection of cake or powderYesYesYesYes
PurityReversed-phase HPLC at 214 nmYesYesYesYes
IdentityLC-MS or MALDI-TOFYes——Yes
Water contentKarl Fischer titrationYes—YesYes
pH (solutions)PotentiometricYesYesYesYes
Assay or contentAmino acid analysis or quantitative HPLCYes——Yes
Mass balanceSummation with counter-ion dataYes——Yes

Appearance is not a cosmetic check. A cake that collapses, shrinks or changes colour usually signals moisture ingress or oxidation before the chromatogram shows it. Water content is the leading indicator for lyophilised material, and identity at the final time point catches hydrolysis that produces a family of peaks too small to integrate individually. The methods behind purity and content are set out in how peptide purity is tested.

Storage is more than temperature

Temperature gets most of the attention, but four other variables drive peptide degradation in practice.

  • Moisture. Store with desiccant in a sealed container, and let the vial reach room temperature before opening so condensation does not form on the powder.
  • Light. Use amber vials or wrap in foil. Aromatic and sulfur-containing residues are the first to react.
  • Oxygen. Repeated opening exchanges the headspace. For oxidation-sensitive sequences, blanket with argon and minimise entries into the vial.
  • Freeze-thaw. Each cycle concentrates solutes at the ice interface and promotes aggregation. Aliquot before freezing rather than freezing and thawing one stock.

A peptide stored at −20 °C in a frost-free freezer that cycles above freezing is not stored at −20 °C. That single detail explains a surprising share of stability complaints, and it is worth checking the freezer log before attributing a purity loss to the manufacturer.

Retest date versus expiry date

The two terms are not interchangeable. An expiry date is a regulatory conclusion: beyond it, the material must not be used, because the manufacturer has not demonstrated that it remains within specification. A retest date is a review point: the material may be used after that date provided it is re-analysed and still conforms. Research peptides are normally labelled with a retest date, because a full expiry assignment would require a formal stability programme that the intended use does not justify.

A defensible retest date comes from data, not from a template. If a supplier prints 24 months on every COA with no study behind it, the number is a convention. Ask what the interval is based on for that sequence. MOL Changes states a storage condition and retest date on the COA and can discuss the supporting data on request; for material going into a regulated programme, plan a formal stability study rather than relying on a research-grade label.

Frequently asked questions

Do peptides expire?

Yes, but research peptides are usually given a retest date rather than an expiry date. Purity can decline through hydrolysis, deamidation, oxidation or aggregation. Once the retest date is reached, the material should be re-analysed before further use, and the result decides whether it can still be used.

How long do peptides last in the freezer?

A lyophilised peptide stored dry at −20 °C commonly remains within specification for 24 months, and longer at −80 °C. Solution stability is much shorter, sometimes weeks. The storage form, the sequence and the moisture level matter more than the freezer temperature alone.

What is forced degradation testing?

It exposes a peptide to acid, base, heat, oxidation and light to generate degradation products on purpose. The aim is to identify likely degradants and confirm that the analytical method separates them from the parent, so a stability study result can be interpreted rather than assumed.

Why did my peptide lose purity in storage?

Common causes are moisture ingress, repeated freeze-thaw, light exposure and storage above the recommended temperature. Hydrolysis and deamidation show as new peaks close to the main peak, while oxidation often appears as a later-eluting hydrophobic peak. Check the freezer log before blaming the batch.

Should peptides be stored as powder or in solution?

Store as dry powder when possible. Water drives hydrolysis and aggregation, so a lyophilised powder at −20 °C is far more stable than a solution. If you must keep a solution, aliquot it, use the recommended buffer and pH, and avoid repeated freeze-thaw cycles.

What does significant change mean in a stability study?

It is a predefined change that invalidates the storage claim, typically a purity drop beyond a set limit, a specified increase in a known degradant, or a failure of appearance or water content. Defining it before the study begins prevents a drifting result from being rationalised afterwards.

Sources and scope

This answer is based on peer-reviewed peptide chemistry and analytical literature, pharmacopoeial requirements (USP <503>, Ph. Eur. 2.2.29 and 2.2.46), FDA and EMA guidance on peptide drug substances, and MOL Changes in-house synthesis and testing data. Product statements describe research-grade peptides supplied for laboratory and manufacturing use. They are not medical advice and are not a substitute for clinical judgement.